AdamLeeFriedlanderMDMSc

Critical Care Medicine

Corporate Director, Critical Care at Orlando Health

Dr. Friedlander is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
86 W. Underwood St.
Suite 101
Orlando, FL 32804
Phone+1 321-841-3704

Fax+1 321-843-5177

Dr. Adam Friedlander is an Intensivist in Orlando, FL and has clinical supervisory responsibility over all of Orlando Health Medical Group’s critical care department. This includes spearheading recruitment efforts and overseeing significant expansion throughout the enterprise, including development of cardiovascular and neurosciecnes critical care service lines. Responsible for standardization of critical care across Orlando Health, including Orlando Regional Medical Center at the downtown campus and 6 community hospitals.

University of Colorado DenverMSc, Clinical Sciences, 2004 - 2011
University of ColoradoFellowship, Pulmonary Disease and Critical Care Medicine, 2005 - 2008
University of ColoradoResidency, Internal Medicine, 2002 - 2004
University of ColoradoInternship, Internal Medicine, 2001 - 2002
University of Miami Leonard M. Miller School of MedicineClass of 2001
University of MiamiBS, Biology, 1997

CMS Meaningful Use Stage 1 Certification PrimeSUITE EHR, Greenway Health, LLC, 2011

PubMed

127 citations
A combined pulmonary-radiology workshop for visual evaluation of COPD: study design, chest CT findings and concordance with quantitative evaluation.
Richard G. Barr, Eugene Berkowitz, Francesca Bigazzi, F. R. Bode, Jessica Bon
COPD. 2012-03-29
93 citations
Phenotypes of Chronic Obstructive Pulmonary Disease
Adam L. Friedlander, David A. Lynch, Liesel A. Dyar, Russell P. Bowler
COPD. 2007-12-01
87 citations
Genome-wide association study of smoking behaviours in patients with COPD.
Mateusz Siedlinski, Michael H. Cho, Per Bakke, Amund Gulsvik, David A. Lomas
Thorax. 2011-10-01

Journal Articles

Assessing the effectiveness of Making the Right Diagnosis: The Need for Spirometry.
Make B, Friedlander AL, Lundstrom N, J ournal of Continuing Education in the Health Professions 2010; 30(1); 7273
Tumor necrosis factor gene polymorphisms are associated with chronic obstructive pulmonary disease.
Gingo MR, Silveira LJ, Miller YE, Friedlander AL, Cosgrove GP, Chan ED, Maier LA, Bowler RP, European Respiratory Journal 2008; 31(5): 1005- 1012
Fatal and near- fatal asthma: phenotypes, precipitating factors, and management.
Friedlander AL, The Respiratory Report 2007; 3(1)

Books/Book Chapters

Oxford American Handbook of Pulmonary Medicine.
Chapter: Asthma
Friedlander ALEditors: Brown K and Lee- Chiong T.Oxford University Press
Bone’s Atlas of Pulmonary Medicine.
Chapter: Severe Asthma
Friedlander AL and Wenzel SAEditors: Crapo J.Current MedicineEdition 4,
Hospital Medicine Secrets.
Chapter: Pneumothorax
Friedlander ALEditors: Glasheen J.Elsevier

Lectures

Monitoring Exhaled Nitric Oxide (eNO) in Asthma.
Asthma Education at the Cutting Edge” Symposium, Savannah, GA
A Polymorphism in the Promoter Region of the VEGF Gene is Associated with Phenoptypes of Chronic Obstructive Pulmonary Disease.
American Thoracic Society International Conference, New Orleans, LA
Nonvalidation of Reported Genetic Risk Factors for COPD in a Large Replication Cohort.
American Thoracic Society International Conference, New Orleans, LA
Quanititative Computed Tomography of Emphysema in Smokers without Airflow Obstruction: A Novel COPD Phenotype?
American Thoracic Society International Conference, New Orleans, LA
Advising and Motivating Smokers to Quit: Tools and Skills for Practitioners.
National Jewish Health targeting pulmonologists and primary care providers throughout rural Colorado
Recognition and Management of COPD.
National Jewish Health targeting primary care providers
Making the Right Diagnosis: The Need for Spirometry.
National Jewish Health and The COPD Foundation, in cooperation with the National Medical Association
The Importance of Clinical, Physiologic and Radiographic Phenotypes in COPD.
American Thoracic Society International Conference, San Diego, CA
Replication of Genetic Risk Factors for COPD.
European Respiratory Society Annual Congress, Berlin, Germany
Defining Novel Phenotypes in COPD: Distinguishing Emphysema from Airways Disease.
American Thoracic Society International Conference, San Francisco, CA
Join now to see all